Mode
Text Size
Log in / Sign up
Phase 4 Completed N=100 Randomized Double-blind Treatment

Posterior Cruciate Retaining (PCR) Versus Posterior Cruciate Substituting (PCS) Total Knee Arthroplasty (TKA)

Arthroplasty, Replacement, Knee · Knee Arthroplasty, Total
Source: ClinicalTrials.gov NCT02429856 ↗
Enrolled (actual)
100
Serious AEs
7.0%
Results posted
May 2019
Primary outcomePrimary: Western Ontario McMaster (WOMAC) Osteoarthritis Index Pain — 84.0; 78.3 units on a scale
◆ Published Evidence
Highly cited
119citations · ~7 / year
Knee range of motion during the first two years after use of posterior cruciate-stabilizing or posterior cruciate-retaining total knee prostheses. A randomized clinical trial.
The Journal of bone and joint surgery. American volume · 2008 · High-confidence link

Summary

This randomized clinical trial (RCT) examined 10 year outcomes comparing SCORPIO™ Posterior Cruciate Substituting (PCS) versus Posterior Cruciate Retaining (PCR) Total Knee Arthroplasty (TKA) as the primary outcome.

Linked Publications

  • Knee range of motion during the first two years after use of posterior cruciate-stabilizing or posterior cruciate-retaining total knee prostheses. A randomized clinical trial.
    The Journal of bone and joint surgery. American volume · 2008 · 119 citations · High-confidence link

Outcome Measures

OutcomeResultp-value
PRIMARY
Western Ontario McMaster (WOMAC) Osteoarthritis Index Pain
84.0; 78.3
PRIMARY
WOMAC Osteoarthritis Index Function
67.9; 72.7
SECONDARY
RAND -36 Health Survey
42.4; 50.3
SECONDARY
Revision Rate
5; 2
SECONDARY
Number of Complications
6; 2
SECONDARY
Knee Range of Motion
105.8; 105.9

Eligibility Criteria

Inclusion Criteria

  • scheduled for primary TKA
  • non-inflammatory arthritis
  • intact Posterior Cruciate Ligament at the time of surgery

Exclusion Criteria

  • required bone grafting of either the femur or tibia
  • varus or valgus deformity of > 15 degrees
  • previous high tibial osteotomy
  • unable to understand or comply with the study requirements
  • unable to provide signed informed consent
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02429856) and the linked publication. Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search